GLOBAL DIAGNOSTIC AND GUIDED INTERVENTIONAL CARDIOLOGY PRODUCTS MARKET

174 Pages | 98 Exhibits | 2017 Analysis | Forecasts Through 2021

OVERVIEW:
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for diagnostic and guided interventional cardiology products.

DIAGNOSTIC AND GUIDED INTERVENTIONAL CARDIOLOGY MARKET HIGHLIGHTS

  • Diagnostic interventional cardiology products are being utilized less frequently in the pre-operative work-up of patients with suspected cardiovascular disease. These technologies are primarily utilized to guide minimally invasive therapies (eg stenting).
  • Angiography devices, including cardiac X-ray systems and transcatheter devices, accounted for 59% of total product sales in 2016. Sales of ICE and OCT systems are expected to experience the strongest growth throughout the forecast period (2016-21).
  • The market for diagnostic and guided interventional cardiology devices is anticipated to experience moderate growth during the forecast period, increasing to an estimated $4.8bn by 2021.
  • The increasing burden of cardiovascular diseases (CVDs) and the growing elderly demographic, a high risk demographic for the development of CVDs, are the main factors driving growth in product sales.
  • The US market for diagnostic and guided interventional cardiology devices accounted for approximately 35% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK). The strongest growth in biopsy product sales is expected to occur in the Rest of the World segment, which is being driven by demand for more sophisticated healthcare services in emering markets.
Topics Covered Include:
  • An overview of diagnostic and guided interventional cardiology devices, including transcatheter angiogrpahy, fraction flow reserve, intracardiac echocardiography (ICE), intravascular ultrasound, optical coherence tomography (OCT), as well as robotic-assisted surgical systems.
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by product segment.
  • Discussion of key drivers and limiters impacting the major product segments.
  • Country and region-specific insights that are influencing the utilization of diagnostic and guided interventional cardiology devices.
  • A review of emerging technologies which could impact sales of existing devices.


TABLE OF CONTENTS:
EXECUTIVE SUMMARY 

i. Cardiovascular diseases overview 
ii. Global diagnostic and guided interventional cardiology products market 
	a. Selected market drivers and limiters 
	b. Device segment insights
	c. Technology trends 
iii. Methodology 

Exhibit ES-1: Diagnostic and guided interventional cardiology products, global market forecast, 2016-21 
Exhibit ES-2: Global diagnostic and guided interventional cardiology products market, share by country/region, 2016 

1. CARDIOVASCULAR DISEASES OVERVIEW 

1.1 Acute coronary syndrome 
	1.1.1 Atherosclerosis 
	1.1.2 Angina pectoris 
	1.1.3 Myocardial infarction 
1.2 Hypertension 
1.3 Cardiomyopathy 
1.4 Congenital heart defects 
1.5 Heart failure 
1.6 Peripheral vascular disease 
1.7 Cerebrovascular disease 
1.8 Bibliography 

Exhibit 1-1: Estimated mortality due to ischemic heart disease and cerebrovascular disease, select countries 
Exhibit 1-2: Top 10 countries with the highest CVD death rates
Exhibit 1-3: Estimated incidence rates for acute coronary syndrome, select countries 
Exhibit 1-4: Age-standardized incidence (000s) of angina pectoris, select regions 
Exhibit 1-5: Clinical classification of acute myocardial infarction 
Exhibit 1-6: Age-standardized incidence (000s) of acute myocardial infarction, select regions 
Exhibit 1-7: Estimated incidence rates for myocardial infarction, select countries 
Exhibit 1-8: Estimated prevalence of hypertension, select countries 
Exhibit 1-9: Mortality attributable to hypertensive diseases, select countries 
Exhibit 1-10: Age-standardized prevalence of heart failure, select regions 
Exhibit 1-11: Estimated prevalence of chronic heart failure, select countries 
Exhibit 1-12: Estimated incidence rates for stroke, select countries 
Exhibit 1-13: Estimated prevalence of stroke, select countries 

2. DIAGNOSTIC AND GUIDED INTERVENTIONAL CARDIOLOGY PRODUCTS
 
2.1 Angiography 
	2.1.1 Angiography catheters 
	2.1.2 Angiography guidewires 
	2.1.3 Cardiovascular X-ray systems 
2.2 Fractional flow reserve 
	2.2.1 Fractional flow reserve products 
2.3 Intracardiac echocardiography 
	2.3.1 Intracardiac echocardiography products 
2.4 Intravascular ultrasound 
	2.4.1 Products 
2.5 Optical coherence tomography 
	2.5.1 Products 
2.6 Robotic-assisted systems 
	2.6.1 Products 
	2.6.2 Emerging technology 
2.7 Bibliography 

Exhibit 2-1: Advantages and disadvantages of conventional angiography 
Exhibit 2-2: Select images of angiography catheters 
Exhibit 2-3: Selected angiography catheters and manufacturers 
Exhibit 2-4: Select images of angiography guidewires 
Exhibit 2-5: Selected angiography guidewires and manufacturers 
Exhibit 2-6: Select images of cardiac X-ray systems 
Exhibit 2-7: Selected cardiac X-ray systems and manufacturers 
Exhibit 2-8: Select images of FFR systems 
Exhibit 2-9: Selected fractional flow reserve systems and manufacturers 
Exhibit 2-10: Advantages and disadvantages of intracardiac echocardiography 
Exhibit 2-11: Select images of intracardiac echocardiography systems 
Exhibit 2-12: Selected intracardiac echocardiography systems and manufacturers 
Exhibit 2-13: Advantages and disadvantages of IVUS 
Exhibit 2-14: Select images of intravascular ultrasound systems 
Exhibit 2-15: Selected intravascular ultrasound systems and manufacturers 
Exhibit 2-16: Advantages and disadvantages of OCT 
Exhibit 2-17: Select images of optical coherence tomography systems 
Exhibit 2-18: Selected optical coherence tomography systems and manufacturers 
Exhibit 2-19: Advantages and disadvantages of robotic-assisted systems 
Exhibit 2-20: Select images of robotic-assisted systems 
Exhibit 2-21: Selected robotic-assisted systems and manufacturers 

3. DIAGNOSTIC AND GUIDED INTERVENTIONAL CARDIOLOGY PRODUCTS MARKET 

3.1 Global competitors 
	3.1.1 Angiography systems competitive analysis 
	3.1.2 Fractional flow reserve systems competitive analysis 
	3.1.3 Intracardiac echocardiography systems competitive analysis 
	3.1.4 Intravascular ultrasound systems competitive analysis 
	3.1.5 Optical coherence tomography systems competitive analysis 
	3.1.6 Robotic-assisted surgical systems competitive analysis 
3.2 Market forecast: US 
	3.2.1 Angiography systems market 
	3.2.2 Fractional flow reservice systems market 
	3.2.3 Intracardiac echocardiography systems market 
	3.2.4 Intravascular ultrasound systems market 
	3.2.5 Optical coherence tomography systems market 
	3.2.6 Robotic-assisted surgical systems market 
3.3 Market forecast: five major EU markets 
	3.3.1 Angiography systems market 
	3.3.2 Fractional flow reserve systems market 
	3.3.3 Intracardiac echocardiography systems market 
	3.3.4 Intravascular ultrasound systems market 
	3.3.5 Optical coherence tomography systems market 
	3.3.6 Robotic-assisted surgical systems market 
3.4 Market forecast: Japan 
	3.4.1 Angiography systems market 
	3.4.2 Fractional flow reserve systems market 
	3.4.3 Intracardiac echocardiography systems market 
	3.4.4 Intravascular ultrasound systems market 
	3.4.5 Optical coherence tomography systems market 
	3.4.6 Robotic-assisted surgical systems market 
3.5 Market forecast: RoW 
	3.5.1 Angiography systems market 
	3.5.2 Fractional flow reserve systems market 
	3.5.3 Intracardiac echocardiography systems market 
	3.5.4 Intravascular ultrasound systems market 
	3.5.5 Optical coherence tomography systems market 
	3.5.6 Robotic-assisted surgical systems market 
3.6 Bibliography 

Exhibit 3-1: Diagnostic and guided interventional cardiology products, global market forecast ($m), 2016-21 
Exhibit 3-2: Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21 
Exhibit 3-3: Average sale price of selected diagnostic and guided interventional cardiology products 
Exhibit 3-4: Global diagnostic and guided interventional cardiology products market, share by country/region, 2016 
Exhibit 3-5: Global diagnostic and guided interventional cardiology product sales by country/region, combined market forecast ($m), 2016-21 
Exhibit 3-6: Global angiography devices market, share by supplier, 2016 
Exhibit 3-7: Global fractional flow reserve systems market, share by supplier, 2016 
Exhibit 3-8: Global intracardiac echocardiography systems market, share by supplier, 2016 
Exhibit 3-9: Global intravascular ultrasound systems market, share by supplier, 2016 
Exhibit 3-10: Global optical coherence tomography systems market, share by supplier, 2016 
Exhibit 3-11: Global robotic-assisted surgical systems market, share by supplier, 2016 
Exhibit 3-12: US Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21 
Exhibit 3-13: US angiography systems, market forecast ($m), 2016-21 
Exhibit 3-14: US angiography devices market, share by supplier, 2016 
Exhibit 3-15: US fractional flow reserve systems, market forecast ($m), 2016-21 
Exhibit 3-16: US fractional flow reserve systems market, share by supplier, 2016 
Exhibit 3-17: US intracardiac echocardiography systems, market forecast ($m), 2016-21 
Exhibit 3-18: US intracardiac echocardiography systems market, share by supplier, 2016 
Exhibit 3-19: US intravascular ultrasound systems, market forecast ($m), 2016-21 
Exhibit 3-20: US intravascular ultrasound systems market, share by supplier, 2016 
Exhibit 3-21: US optical coherence tomography systems, market forecast ($m), 2016-21 
Exhibit 3-22: US robotic-assisted surgical systems, market forecast ($m), 2016-21 
Exhibit 3-23: US robotic-assisted surgical systems market, share by supplier, 2016 
Exhibit 3-24: 5EU Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21
Exhibit 3-25: 5EU angiography systems, market forecast ($m), 2016-21 
Exhibit 3-26: 5EU angiography devices market, share by supplier, 2016 
Exhibit 3-27: 5EU fractional flow reserve systems, market forecast ($m), 2016-21 
Exhibit 3-28: 5EU fractional flow reserve systems market, share by supplier, 2016 
Exhibit 3-29: 5EU intracardiac echocardiography systems, market forecast ($m), 2016-21 
Exhibit 3-30: 5EU intracardiac echocardiography systems market, share by supplier, 2016 
Exhibit 3-31: 5EU intravascular ultrasound systems, market forecast ($m), 2016-21 
Exhibit 3-32: 5EU intravascular ultrasound systems market, share by supplier, 2016 
Exhibit 3-33: 5EU optical coherence tomography systems, market forecast ($m), 2016-21 
Exhibit 3-34: 5EU optical coherence tomography systems market, share by supplier, 2016 
Exhibit 3-35: 5EU robotic-assisted surgical systems, market forecast ($m), 2016-21 
Exhibit 3-36: 5EU robotic-assisted surgical systems market, share by supplier, 2016 
Exhibit 3-37: Japan Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21 
Exhibit 3-38: Japan angiography systems, market forecast ($m), 2016-21 
Exhibit 3-39: Japan angiography devices market, share by supplier, 2016 
Exhibit 3-40: Japan fractional flow reserve systems, market forecast ($m), 2016-21 
Exhibit 3-41: Japan fractional flow reserve systems market, share by supplier, 2016 
Exhibit 3-42: Japan intracardiac echocardiography systems, market forecast ($m), 2016-21 
Exhibit 3-43: Japan intracardiac echocardiography systems market, share by supplier, 2016 
Exhibit 3-44: Japan intravascular ultrasound systems, market forecast ($m), 2016-21 
Exhibit 3-45: Japan intravascular ultrasound systems market, share by supplier, 2016 
Exhibit 3-46: Japan optical coherence tomography systems, market forecast ($m), 2016-21 
Exhibit 3-47: Japan optical coherence tomography systems market, share by supplier, 2016 
Exhibit 3-48: Japan robotic-assisted surgical systems, market forecast ($m), 2016-21 
Exhibit 3-49: Japan robotic-assisted surgical systems market, share by supplier, 2016 
Exhibit 3-50: RoW diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21
Exhibit 3-51: RoW angiography systems, market forecast ($m), 2016-21 
Exhibit 3-52: RoW angiography devices market, share by supplier, 2016 
Exhibit 3-53: RoW fractional flow reserve systems, market forecast ($m), 2016-21 
Exhibit 3-54: RoW fractional flow reserve systems market, share by supplier, 2016 
Exhibit 3-55: RoW intracardiac echocardiography systems, market forecast ($m), 2016-21 
Exhibit 3-56: RoW intracardiac echocardiography systems market, share by supplier, 2016 
Exhibit 3-57: RoW intravascular ultrasound systems, market forecast ($m), 2016-21 
Exhibit 3-58: RoW intravascular ultrasound systems market, share by supplier, 2016 
Exhibit 3-59: RoW optical coherence tomography systems, market forecast ($m), 2016-21 
Exhibit 3-60: RoW optical coherence tomography systems market, share by supplier, 2016 
Exhibit 3-61: RoW robotic-assisted surgical systems, market forecast ($m), 2016-21 
Exhibit 3-62: RoW robotic-assisted surgical systems market, share by supplier, 2016 

APPENDIX: COMPANY LISTING


COMPANIES COVERED:

  1. Abbott
  2. ACIST Medical Systems/Bracco Group
  3. Allengers
  4. Alvimedica
  5. Amecath
  6. AMG International
  7. AngioDynamics
  8. Argon Medical Devices
  9. Asahi Intecc
  10. Auris Surgical Robotics
  11. B. Braun Medical/B. Braun Melsungen
  12. Baihe Medical
  13. Biosense Webster/Johnson & Johnson
  14. Boston Scientific
  15. Bracco Group
  16. Cardinal Health
  17. Catheter Precision
  18. Conavi Medical
  19. Cook Medical/Cook Group
  20. Cordis/Cardinal Health
  21. Corindus Vascular Robotics
  22. Curative Medical
  23. GE Healthcare/General Electric
  24. Hansen Medical/Auris Surgical Robotics
  25. Infraredx/Nipro
  26. InSitu Technologies
  27. Intuitive Surgical
  28. Johnson & Johnson
  29. JOTEC
  30. Lepu Medical
  31. Medtronic
  32. Merit Medical Systems
  33. Nipro
  34. Occlutech
  35. Opsens Medical/Opsens
  36. Oscor
  37. Penumbra
  38. Philips/Royal Philips
  39. Siemens Healthineers/Siemens
  40. Shimadzu Medical Systems/Shimadzu
  41. St. Jude Medical/Abbott
  42. Stereotaxis
  43. Terumo Interventional Systems
  44. Toshiba America Medical Systems/Canon
Contact Us

Need help finding medtech research? Let us help you!